FRONTEO and Santen Launch Second Phase of Co-Creation Project
FRONTEO Inc. has announced the launch of the second phase of its co-creation project with Santen Pha… · 2026-07-16
株式会社FRONTEO News Releases
FRONTEO and Daiichi Sankyo Develop Predictive Model to Automatically Extract Toxicological Interpretations from Toxicity Test Reports
FRONTEO and Daiichi Sankyo have jointly developed a predictive model using the equation-driven AI 'K… · 2026-07-14
FRONTEO President and CEO Masahiro Morimoto Delivers Lecture at American University in Washington D.C.
FRONTEO, Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereinafter "FR… · 2026-06-30
FRONTEO Announces FLLP Legal Video Platform Membership Surpasses 22,000 Users
FRONTEO Inc. announces that membership of its FLLP (FRONTEO Legal Link Portal), Japan's largest memb… · 2026-07-03
FRONTEO to Host Research Support Program Offering 1-Year Access to Medical Paper Search AI "KIBIT Amanogawa" for Universities and Research Institutions
FRONTEO, Inc. (Headquarters: Minato-ku, Tokyo; President and CEO: Masahiro Morimoto; hereinafter "FR… · 2026-07-07
FRONTEO and Keio University School of Medicine Acquire Two Patents for Conversational AI Program Supporting Depression Diagnosis
FRONTEO Inc. and Keio University School of Medicine have jointly developed and patented two conversa… · 2026-03-31
FRONTEO Develops 'Research Security and Risk Management System' Utilizing In-House Developed AI 'KIBIT' in Cabinet Office Project
FRONTEO developed a research security and risk management system using its AI 'KIBIT' as part of a C… · 2026-04-13
FRONTEO and Astellas Pharma Sign Agreement on Target Molecule Discovery
AI company FRONTEO and Astellas Pharma have signed an agreement regarding target molecule discovery … · 2026-04-16
FRONTEO and Keio University School of Medicine Acquire Two Patents for Conversational AI Program Supporting Depression Diagnosis
FRONTEO Inc. and Keio University School of Medicine have jointly developed and patented two conversa… · 2026-03-31
"Talk Lab KIBIT," a Conversational AI-Powered "Brain Health" Assessment Web Application, to be Offered Through Asahi Mutual Life Insurance's "Everyone's Relief 100-Year Project"
AI application developed by FRONTEO and Shionogi to be offered as part of Asahi Mutual Life Insuranc… · 2026-03-29
FRONTEO and Tokyo Tech Establish Industry-Academia Collaborative Research Center for AI Drug Discovery
FRONTEO Inc. and National University Corporation Tokyo Institute of Science and Technology (Tokyo Te… · 2026-04-27
FRONTEO's Medical Literature Search AI 'KIBIT Amanogawa' Fully Adopted by GeneNet for Finding Anti-aging Components in Industrial Waste
FRONTEO announced the full adoption of its medical paper discovery AI system 'KIBIT Amanogawa' by Ge… · 2026-04-23
Mr. Toshiharu Tanaka (Former Senior Executive Officer and Head of Economic Security at Sumitomo Heavy Industries) Appointed as Advisor at FRONTEO
FRONTEO has appointed Toshiharu Tanaka, former Head of Economic Security at Sumitomo Heavy Industrie… · 2026-04-09
FRONTEO AI Innovation Forum 2026 to Feature AI Drug Discovery Success Cases from Five Pharma Companies
FRONTEO will host the 'FRONTEO AI Innovation Forum 2026' on July 23, 2026. Five pharmaceutical compa… · 2026-06-09
University of Oklahoma Confirms Cell Proliferation Suppression Effect of Novel Pancreatic Cancer Target Molecule Candidates Discovered by FRONTEO's AI
FRONTEO的AI創藥服務發現之胰臟癌新標靶分子，獲奧克拉荷馬大學證實具抑制細胞增生效果。 · 2026-05-13
FRONTEO Opens Its Own AI Drug Discovery Base 'KIBIT AI Biology Lab'
FRONTEO 宣布開設專屬 AI 新藥研發基地「KIBIT AI Biology Lab」，作為推動 AI 創藥事業與產學合作的核心樞紐。 · 2026-05-13
FRONTEO Integrates Generative AI into Unstructured Data Analysis AI 'KIBIT Libria'
FRONTEO has integrated generative AI capabilities into its 'KIBIT Libria' solution for analyzing uns… · 2026-05-21
FRONTEO CEO Masahiro Morimoto Invited to Deliver Special Lecture at 'Medical Industry Growth Strategy Seminar Annual Forum 2026'
FRONTEO CEO Masahiro Morimoto will speak at the 'Medical Industry Growth Strategy Seminar Annual For… · 2026-06-02
FRONTEO and Scohia Pharma Sign Agreement for New Indication Discovery Using AI Drug Discovery Service 'DDAIF'
FRONTEO has signed an agreement with Scohia Pharma to explore new indications for its compounds usin… · 2026-05-28
University of Oklahoma Confirms Cell Proliferation Inhibitory Effect of Novel Pancreatic Cancer Target Molecule Candidates Discovered by FRONTEO's AI Drug Discovery Support Service "Drug Discovery AI Factory"
FRONTEO and the University of Oklahoma have confirmed the cell proliferation inhibitory effect of no… · 2026-05-13
FRONTEO Opens 'KIBIT AI Biology Lab,' Its Own AI Drug Discovery Center
FRONTEO Inc. has opened the 'KIBIT AI Biology Lab,' a hub for its AI-powered drug discovery. This fa… · 2026-05-13
FRONTEO and Tokyo Tech Establish Industry-Academia Collaborative Research Center for AI Drug Discovery
FRONTEO Inc. and National University Corporation Tokyo Institute of Science and Technology (Tokyo Te… · 2026-04-27
FRONTEO's Medical Literature Search AI 'KIBIT Amanogawa' Fully Adopted by GeneNet for Finding Anti-aging Components in Industrial Waste
FRONTEO announced the full adoption of its medical paper discovery AI system 'KIBIT Amanogawa' by Ge… · 2026-04-23
FRONTEO and Astellas Pharma Sign Agreement on Target Molecule Discovery
AI company FRONTEO and Astellas Pharma have signed an agreement regarding target molecule discovery … · 2026-04-16
FRONTEO Develops 'Research Security and Risk Management System' Utilizing In-House Developed AI 'KIBIT' in Cabinet Office Project
FRONTEO developed a research security and risk management system using its AI 'KIBIT' as part of a C… · 2026-04-13
FRONTEO and Keio University School of Medicine Acquire Two Patents for Conversational AI Program Supporting Depression Diagnosis
FRONTEO Inc. and Keio University School of Medicine have jointly developed and patented two conversa… · 2026-03-31